Modulation of 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine-Induced Mutation in the Cecum and Colon of Big Blue Rats by Conjugated Linoleic Acid and 1,2-Dithiole-3-Thione

Nutrition and Cancer

Volumn 39, Issue 2, 2001, Pages 259-266

  Yang, Haiyan ^a   Stuart, Gregory R ^a   Glickman, Barry W ^a   De Boer, Johan G ^a  

^a UNIVERSITY OF VICTORIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DITHIOL 3 THIONE; 1,2-DITHIOL-3-THIONE; 2 AMINO 1 METHYL 6 PHENYLIMIDAZO(4,5 B)PYRIDINE; 2-AMINO-1-METHYL-6-PHENYLIMIDAZO(4,5-B)PYRIDINE; ANTIMUTAGENIC AGENT; ANTINEOPLASTIC AGENT; BACTERIAL PROTEIN; IMIDAZOLE DERIVATIVE; LACI PROTEIN; LINOLEIC ACID; MUTAGENIC AGENT; REPRESSOR PROTEIN; THIOKETONE; THIOPHENE DERIVATIVE;

ANIMAL; ARTICLE; CECUM; COLON; DIET; DRUG EFFECT; EATING; FRAMESHIFT MUTATION; GENETICS; MALE; RAT; RAT STRAIN; TRANSGENIC ANIMAL; WEIGHT GAIN;

ANIMAL; ANIMALS, GENETICALLY MODIFIED; ANTICARCINOGENIC AGENTS; ANTIMUTAGENIC AGENTS; BACTERIAL PROTEINS; CECUM; COLON; DIET; EATING; FRAMESHIFT MUTATION; IMIDAZOLES; LINOLEIC ACID; MALE; MUTAGENS; RATS; RATS, INBRED F344; REPRESSOR PROTEINS; THIONES; THIOPHENES; WEIGHT GAIN;

EID: 0035226223     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/S15327914nc392_16     Document Type: Article

References (54)

1. Doll, R, and Peto, R: The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. JNCI 66, 1191-1308, 1981.
2. Stoner, GD, Morse, MA, and Kelloff, GJ: Perspectives in cancer chemoprevention. Environ Health Perspect 105 Suppl 4, 945-954, 1997.
3. Boring, CC, Squires, TS, Tong, T, and Montgomery, S: Cancer statistics, 1994. CA Cancer J Clin 44, 7-26, 1994.
4. Krishnan, K, Ruffin, MT, and Brenner, DE: Clinical models of chemoprevention for colon cancer. Hematol Oncol Clin North Am 12, 1079-1113, 1998.
5. Bingham, SA: High-meat diets and cancer risk. Proc Nutr Soc 58, 243-248, 1999.
6. Hsing, AW, McLaughlin, JK, Chow, WH, Schuman, LM, Co Chien, HT, et al.: Risk factors for colorectal cancer in a prospective study among US white men. Int J Cancer 77, 549-553, 1998.
7. Nagao, M, and Sugimura, T: Carcinogenic factors in food with relevance to colon cancer development. Mutat Res 290, 43-51, 1993.
8. Shirai, T, Cui, L, Takahashi, S, Futakuchi, M, Asamoto, M, et al.: Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) in the rat prostate and induction of invasive carcinomas by subsequent treatment with testosterone propionate. Cancer Lett 143, 217-221, 1999.
9. Ito, N, Hasegawa, R, Sano, M, Tamano, S, Esumi, H, et al.: A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis 12, 1503-1506, 1991.
10. Okonogi, H, Stuart, GR, Okochi, E, Ushijima, T, Sugimura, T, et al.: Effects of gender and species on spectra of mutation induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the lacI transgene. Mutat Res 395, 93-99, 1997.
11. 32P-postlabeling. Chem Res Toxicol 7, 733-739, 1994.
12. Huber, WW, McDaniel, LP, Kaderlik, KR, Teitel, CH, Lang, NP, et al.: Chemoprotection against the formation of colon DNA adducts from the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat. Mutat Res 376, 115-122, 1997.
13. 14C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans. Carcinogenesis 20, 705-713, 1999.
14. Nowell, SA, Massengill, JS, Williams, S, Radominska-Pandya, A, Tephly, TR, et al.: Glucuronidation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human microsomal UDP-glucuronosyltransferases: identification of specific UGT1A family isoforms involved. Carcinogenesis 20, 1107-1114, 1999.
15. Alexander, J, Fossum, BH, Reistad, R, and Holme, JA: Metabolism of the food carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat and other rodents. In Heterocyclic Amines in Cooked Foods: Possible Human Carcinogens, RH Adamson (ed). Princeton, NJ: Princeton Scientific, 1995, pp 113-122.
16. Ip, C, Singh, M, Thompson, HJ, and Scimeca, JA: Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res 54, 1212-1215, 1994.
17. Ha, YL, Grimm, NK, and Pariza, MW: Newly recognized anticarcinogenic fatty acids: identification and quantification in natural and processed cheeses. J Agric Food Chem 37, 75-81, 1989.
18. Thompson, H, Zhu, Z, Banni, S, Darcy, K, Loftus, T, et al.: Morphological and biochemical status of the mammary gland as influenced by conjugated linoleic acid: implication for a reduction in mammary cancer risk. Cancer Res 57, 5067-5072, 1997.
19. Liew, C, Schut, HA, Chin, SF, Pariza, MW, and Dashwood, RH: Protection of conjugated linoleic acids against 2-amino-3-methylimidazo[4,5-f]quinoline-induced colon carcinogenesis in the F344 rat: a study of inhibitory mechanisms. Carcinogenesis 16, 3037-3043, 1995.
20. Ip, C, Singh, M, Thompson, HJ, and Scimeca, JA: Conjugated linoleic acid suppresses mammary carcinogenesis and proliferative activity of the mammary gland in the rat. Cancer Res 54, 1212-1215, 1994.
21. McMichael, AJ, McCall, MG, Hartshorne, JM, and Woodings, TL: Patterns of gastro-intestinal cancer in European migrants to Australia: the role of dietary change. Int J Cancer 25, 431-437, 1980.
22. Rosen, M, Nystrom, L, and Wall, S: Diet and cancer mortality in the counties of Sweden. Am J Epidemiol 127, 42-49, 1988.
23. Banni, S, Angioni, E, Casu, V, Melis, MP, Carta, G, et al.: Decrease in linoleic acid metabolites as a potential mechanism in cancer risk reduction by conjugated linoleic acid. Carcinogenesis 20, 1019-1024, 1999.
24. Shultz, TD, Chew, BP, Seaman, WR, and Luedecke, LO: Inhibitory effect of conjugated dienoic derivatives of linoleic acid and β-carotene on the in vitro growth of human cancer cells. Cancer Lett 63, 125-133, 1992.
25. Durgam, VR, and Femandes, G: The growth inhibitory effect of conjugated linoleic acid on MCF-7 cells is related to estrogen response system. Cancer Lett 116, 121-130, 1997.
26. Josyula, S, and Schut, HA: Effects of dietary conjugated linoleic acid on DNA adduct formation of PhIP and IQ after bolus administration to female F344 rats. Nutr Cancer 32, 139-145, 1998.
27. Zhu, H, Li, Y, and Trush, MA: Differences in xenobiotic detoxifying activities between bone marrow stromal cells from mice and rats: implications for benzene-induced hematotoxicity. J Toxicol Environ Health 46, 183-201, 1995.
28. Kensler, TW, Groopman, JD, Eaton, DL, Curphey, TJ, and Roebuck, BD: Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofunctional enzyme inducer 1,2-dithiole-3-thione. Carcinogenesis 13, 95-100, 1992.
29. Bolton, MG, Munoz, A, Jacobson, LP, Groopman, JD, Maxuitenko, YY, et al.: Transient intervention with oltipraz protects against aflatoxin-induced hepatic tumorigenesis. Cancer Res 53, 3499-3504, 1993.
30. Rao, CV, Rivenson, A, Zang, E, Steele, V, Kelloff, G, et al.: Inhibition of 2-amino-1-methyl-6-phenylimidazo[4,5]pyridine-induced lymphoma formation by oltipraz. Cancer Res 56, 3395-3398, 1996.
31. Ansher, SS, Dolan, P, and Bueding, E: Biochemical effects of dithiolthiones. Food Chem Toxicol 24, 405-415, 1986.
32. Kohler, SW, Provost, GS, Fieck, A, Kretz, PL, Bullock, WO, et al.: Spectra of spontaneous and mutagen-induced mutations in the lacI gene in transgenic mice. Proc Natl Acad Sci USA 88, 7958-7962, 1991.
33. de Boer, JG, Mirsalis, JC, Provost, GS, Tindall, KR, and Glickman, BW: Spectrum of mutations in kidney, stomach, and liver from lacI transgenic mice recovered after treatment with tris(2,3-dibromopropyl) phosphate. Environ Mol Mutagen 28, 418-423, 1996.
34. 1. Carcinogenesis 17, 2347-2356, 1996.
35. Erfle, HL, Walsh, DF, Holcroft, J, Hague, N, de Boer, JG, et al.: An efficient laboratory protocol for the sequencing of large numbers of lacI mutants recovered from Big Blue transgenic animals. Environ Mol Mutagen 28, 393-396, 1996.
36. Carr, GJ, and Gorelick, NJ: Statistical design and analysis of mutation studies in transgenic mice. Environ Mol Mutagen 25, 246-255, 1995.
37. Adams, WT, and Skopek, TR: Statistical test for the comparison of samples from mutational spectra. J Mol Biol 194, 391-396, 1987.
38. Stuart, GR, de Boer, JG, Haesevoets, R, Holocroft, J, Kangas, J, et al.: Mutations induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in cecum, proximal, and distal colon of lacI transgenic rats. Mutagenesis 16, 431-437, 2001.
39. Hammons, GJ, Fletcher, JV, Stepps, KR, Smith, EA, Balentine, DA, et al.: Effects of chemoprotective agents on the metabolic activation of the carcinogenic arylamines PhIP and 4-aminobiphenyl in human and rat liver microsomes. Nutr Cancer 33, 46-52, 1999.
40. Pell, JD, Gee, JM, Wortley, GM, and Johnson, IT: Dietary corn oil and guar gum stimulate intestinal crypt cell proliferation in rats by independent but potentially synergistic mechanisms. J Nutr 122, 2447-2456, 1992.
41. Lee, DY, Chapkin, RS, and Lupton, JR: Dietary fat and fiber modulate colonic cell proliferation in an interactive site-specific manner. Nutr Cancer 20, 107-118, 1993.
42. Wade, AE, Harley, W, and Bunce, OR: The effects of dietary corn oil on the metabolism and mutagenic activation on N-nitrosodimethylamine (DMN) by hepatic microsomes from male and female rats. Mutat Res 102, 113-121, 1982.
43. Woutersen, RA, Appel, MJ, Garderen-Hoetmer, A, and Wijnands, MV: Dietary fat and carcinogenesis. Mutat Res 443, 111-127, 1999.
44. Josyula, S, and Schut, HA: Dietary ω-3 fatty acids as potential inhibitors of carcinogenesis: effect on DNA adduct formation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice and rats. Food Chem Toxicol 37, 287-296, 1999.
45. Schut, HA, and Yao, R: Tea as a potential chemopreventive agent in PhIP carcinogenesis: effects of green tea and black tea on PhIP-DNA adduct formation in female F-344 rats. Nutr Cancer 36, 52-58, 2000.
46. Ochiai, M, Watanabe, M, Kushida, H, Wakabayashi, K, Sugimura, T, et al.: DNA adduct formation, cell proliferation and aberrant crypt focus formation induced by PhIP in male and female rat colon with relevance to carcinogenesis. Carcinogenesis 17, 95-98, 1996.
47. Tsukamoto, T, Kozaki, K, Nishikawa, Y, Yamamoto, M, Fukami, H, et al.: Development and distribution of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced aberrant crypt foci in the rat large intestine. Jpn J Cancer Res 90, 720-725, 1999.
48. Cummings, DA, and Schut, HA: Removal of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the male Fischer-344 rat. Carcinogenesis 15, 2623-2628, 1994.
49. Hall, C, Youngs, D, and Keighley, MR: Crypt cell production rates at various sites around the colon in Wistar rats and humans. Gut 33, 1528-1531, 1992.
50. Liu, T, Mokuolu, AO, Rao, CV, Reddy, BS, and Holt, PR: Regional chemoprevention of carcinogen-induced tumors in rat colon. Gastroenterology 109, 1167-1172, 1995.
51. Tsukamura, M, Goto, H, Arisawa, T, Hayakawa, T, Nakai, N, et al.: Dietary maltitol decreases the incidence of 1,2-dimethylhydrazine-induced cecum and proximal colon tumors in rats. J Nutr 128, 536-540, 1998.
52. Josyula, S, He, YH, Ruch, RJ, and Schut, HA: Inhibition of DNA adduct formation of PhIP in female F344 rats by dietary conjugated linoleic acid. Nutr Cancer 32, 132-138, 1998.
53. Izzotti, A, Camoirano, A, Cartiglia, C, Grubbs, CJ, Lubet, RA, et al.: Patterns of DNA adduct formation in liver and mammary epithelial cells of rats treated with 7,12-dimethylbenz[a]anthracene, and selective effects of chemopreventive agents. Cancer Res 59, 4285-4290, 1999.
54. Pariza, MW, Loretz, LJ, Storkson, JM, and Holland, NC: Mutagens and modulator of mutagenesis in fried ground beef. Cancer Res 43, 2444s-2446s, 1983.